comparemela.com

Page 7 - Hyperion Capital Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Canada s Organigram buys cannabis edibles maker to tap red-hot demand

Canada s Organigram buys cannabis edibles maker to tap red-hot demand Reuters 1 hr ago April 6 (Reuters) - Organigram Holdings Inc said on Tuesday it has acquired The Edibles & Infusions Corp (EIC) in a C$35 million ($27.88 million) stock deal, as the cannabis producer looks to tap surging demand for pot-based edibles and soft chews. Popular Searches The U.S.-listed shares of Organigram were up 2% at $3.56 in premarket trade, after the Canadian company announced its deal with Vancouver-based pot firm AgraFlora Organics International Inc, which owns 43% of EIC. Pot edibles, like gummy bears, brownies and drinks, have been the biggest beneficiaries of a demand windfall for cannabis-related companies during the pandemic, as consumers stuck at home spent more on their products.

Organigram acquires edibles company in $35-million deal to tap red-hot demand

Organigram acquires edibles company in $35-million deal to tap red-hot demand The Canadian Press Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer John Morris/The Globe and Mail Organigram Holdings Inc said on Tuesday it has acquired The Edibles & Infusions Corp (EIC) in a $35 million stock deal, as the cannabis producer looks to tap surging demand for pot-based edibles and soft chews. The U.S.-listed shares of Organigram were up 2 per cent at US$3.56 in premarket trade, after the Canadian company announced its deal with Vancouver-based pot firm AgraFlora Organics International Inc , which owns 43 per cent of EIC.

IM Cannabis to Acquire Canadian LP MYM Nutraceuticals for $87 Million in Stock – New Cannabis Ventures

April 1, 2021 at 9:52 am Published by NCV Newswire IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Subsidiary, Highland Grow Highland Grow is currently profitable on an EBITDA basis and the Transaction is expected to be immediately accretive to IMC Highland Grow is expected to generate net revenue of $29 million and $38 million and gross margins of 34% to 36% in 2021 and 2022, respectively [1] Purchase price implies 2.3x net revenue and 6.7x EBITDA in 2022 with synergies MYM shareholders will receive 0.022 IMC shares for each MYM share, representing a price of $0.195 based on respective closing prices on March 31, 2021 Super premium positioning, complementary brands, enhanced distribution and export opportunities to Israel and European markets

IM Cannabis Corp : IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Subsidiary, Highland Grow

IM Cannabis Corp : IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Subsidiary, Highland Grow
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.